Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05275673
Title A Study of Sapanisertib in Relapsed/Refractory NFE2L2-Mutated and Wild-Type Squamous Non-Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Calithera Biosciences, Inc
Indications

lung squamous cell carcinoma

Therapies

Sapanisertib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UC Davis Comprehensive Cancer Center Recruiting Davis California 95817 United States Details
Providence Medical Group Santa Rosa - Cancer Center Recruiting Santa Rosa California 95403 United States Details
Norton Cancer Institute, Downtown Recruiting Louisville Kentucky 40202 United States Details
Karmanos Cancer Institute Recruiting Detroit Michigan 48201 United States Details
Zangmeister Cancer Center Recruiting Columbus Ohio 43219 United States Details
Providence Cancer Institute Franz Clinic Not yet recruiting Portland Oregon 97213 United States Details
Tennessee Oncology Recruiting Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field